US20040048813A1 - Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs - Google Patents
Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs Download PDFInfo
- Publication number
- US20040048813A1 US20040048813A1 US10/638,452 US63845203A US2004048813A1 US 20040048813 A1 US20040048813 A1 US 20040048813A1 US 63845203 A US63845203 A US 63845203A US 2004048813 A1 US2004048813 A1 US 2004048813A1
- Authority
- US
- United States
- Prior art keywords
- composition
- agents
- stabilizers
- spinosyn
- glycol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 114
- 238000000034 method Methods 0.000 title claims abstract description 59
- 230000003151 ovacidal effect Effects 0.000 title claims description 40
- 230000003038 pediculicidal effect Effects 0.000 title claims description 31
- 235000013601 eggs Nutrition 0.000 title description 44
- 231100000194 ovacidal Toxicity 0.000 title description 19
- 208000028454 lice infestation Diseases 0.000 title description 11
- 241000517307 Pediculus humanus Species 0.000 title description 10
- 238000011282 treatment Methods 0.000 title description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims abstract description 69
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 54
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 claims abstract description 45
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 42
- 241001674048 Phthiraptera Species 0.000 claims abstract description 39
- SRJQTHAZUNRMPR-UHFFFAOYSA-N spinosyn A Natural products CC1C(=O)C2=CC3C4CC(OC5C(C(OC)C(OC)C(C)O5)OC)CC4C=CC3C2CC(=O)OC(CC)CCCC1OC1CCC(N(C)C)C(C)O1 SRJQTHAZUNRMPR-UHFFFAOYSA-N 0.000 claims abstract description 33
- SRJQTHAZUNRMPR-UYQKXTDMSA-N spinosyn A Chemical compound O([C@H]1CCC[C@@H](OC(=O)C[C@H]2[C@@H]3C=C[C@@H]4C[C@H](C[C@H]4[C@@H]3C=C2C(=O)[C@@H]1C)O[C@H]1[C@@H]([C@H](OC)[C@@H](OC)[C@H](C)O1)OC)CC)[C@H]1CC[C@H](N(C)C)[C@@H](C)O1 SRJQTHAZUNRMPR-UYQKXTDMSA-N 0.000 claims abstract description 32
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 claims abstract description 31
- RDECBWLKMPEKPM-UHFFFAOYSA-N spinosyn D Natural products CC1C(=O)C2=CC3C4CC(OC5C(C(OC)C(OC)C(C)O5)OC)CC4C(C)=CC3C2CC(=O)OC(CC)CCCC1OC1CCC(N(C)C)C(C)O1 RDECBWLKMPEKPM-UHFFFAOYSA-N 0.000 claims abstract description 28
- RDECBWLKMPEKPM-PSCJHHPTSA-N spinosyn D Chemical compound O([C@H]1CCC[C@@H](OC(=O)C[C@H]2[C@@H]3C=C(C)[C@@H]4C[C@H](C[C@H]4[C@@H]3C=C2C(=O)[C@@H]1C)O[C@H]1[C@@H]([C@H](OC)[C@@H](OC)[C@H](C)O1)OC)CC)[C@H]1CC[C@H](N(C)C)[C@@H](C)O1 RDECBWLKMPEKPM-PSCJHHPTSA-N 0.000 claims abstract description 28
- -1 stearyl alcohols Chemical class 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229940043375 1,5-pentanediol Drugs 0.000 claims abstract description 17
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229940051250 hexylene glycol Drugs 0.000 claims abstract description 16
- 235000019445 benzyl alcohol Nutrition 0.000 claims abstract description 15
- SFVFIFLLYFPGHH-UHFFFAOYSA-M stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 claims abstract description 15
- YHHHHJCAVQSFMJ-FNORWQNLSA-N (3e)-deca-1,3-diene Chemical compound CCCCCC\C=C\C=C YHHHHJCAVQSFMJ-FNORWQNLSA-N 0.000 claims abstract description 14
- 229940073669 ceteareth 20 Drugs 0.000 claims abstract description 14
- 229920006037 cross link polymer Polymers 0.000 claims abstract description 14
- QCZAWDGAVJMPTA-RNFRBKRXSA-N ClC1=CC=CC(=N1)C1=NC(=NC(=N1)N[C@@H](C(F)(F)F)C)N[C@@H](C(F)(F)F)C Chemical compound ClC1=CC=CC(=N1)C1=NC(=NC(=N1)N[C@@H](C(F)(F)F)C)N[C@@H](C(F)(F)F)C QCZAWDGAVJMPTA-RNFRBKRXSA-N 0.000 claims abstract description 13
- 229940057981 stearalkonium chloride Drugs 0.000 claims abstract description 12
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims abstract description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 65
- 239000005930 Spinosad Substances 0.000 claims description 39
- 229940014213 spinosad Drugs 0.000 claims description 39
- 239000003381 stabilizer Substances 0.000 claims description 36
- JFLRKDZMHNBDQS-UCQUSYKYSA-N CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C Chemical compound CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C JFLRKDZMHNBDQS-UCQUSYKYSA-N 0.000 claims description 35
- 239000002904 solvent Substances 0.000 claims description 25
- 210000004209 hair Anatomy 0.000 claims description 24
- 241000894007 species Species 0.000 claims description 21
- 241001427556 Anoplura Species 0.000 claims description 20
- 239000003995 emulsifying agent Substances 0.000 claims description 15
- 230000003750 conditioning effect Effects 0.000 claims description 14
- 229930185156 spinosyn Natural products 0.000 claims description 13
- 239000000126 substance Substances 0.000 claims description 13
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 12
- 241000868102 Saccharopolyspora spinosa Species 0.000 claims description 12
- 239000003963 antioxidant agent Substances 0.000 claims description 10
- 239000004909 Moisturizer Substances 0.000 claims description 9
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 9
- 230000001333 moisturizer Effects 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 239000000839 emulsion Substances 0.000 claims description 8
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 claims description 8
- 229960004592 isopropanol Drugs 0.000 claims description 8
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims description 8
- 229920001577 copolymer Polymers 0.000 claims description 7
- 239000003002 pH adjusting agent Substances 0.000 claims description 7
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 239000003760 tallow Substances 0.000 claims description 5
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims description 4
- RPZANUYHRMRTTE-UHFFFAOYSA-N 2,3,4-trimethoxy-6-(methoxymethyl)-5-[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane;1-[[3,4,5-tris(2-hydroxybutoxy)-6-[4,5,6-tris(2-hydroxybutoxy)-2-(2-hydroxybutoxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]butan-2-ol Chemical compound COC1C(OC)C(OC)C(COC)OC1OC1C(OC)C(OC)C(OC)OC1COC.CCC(O)COC1C(OCC(O)CC)C(OCC(O)CC)C(COCC(O)CC)OC1OC1C(OCC(O)CC)C(OCC(O)CC)C(OCC(O)CC)OC1COCC(O)CC RPZANUYHRMRTTE-UHFFFAOYSA-N 0.000 claims description 4
- CYMRPDYINXWJFU-UHFFFAOYSA-N 2-carbamoylbenzoic acid Chemical compound NC(=O)C1=CC=CC=C1C(O)=O CYMRPDYINXWJFU-UHFFFAOYSA-N 0.000 claims description 4
- WBXUUAMKUGUMTA-UHFFFAOYSA-N 6-carbamoyl-2,3-dioctadecylbenzoic acid Chemical compound CCCCCCCCCCCCCCCCCCC1=CC=C(C(N)=O)C(C(O)=O)=C1CCCCCCCCCCCCCCCCCC WBXUUAMKUGUMTA-UHFFFAOYSA-N 0.000 claims description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 229920002125 Sokalan® Polymers 0.000 claims description 4
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims description 4
- 125000002252 acyl group Chemical group 0.000 claims description 4
- 239000008119 colloidal silica Substances 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- 150000004665 fatty acids Chemical class 0.000 claims description 4
- 150000004676 glycans Chemical class 0.000 claims description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 4
- 229920000609 methyl cellulose Polymers 0.000 claims description 4
- 239000001923 methylcellulose Substances 0.000 claims description 4
- 229920001282 polysaccharide Polymers 0.000 claims description 4
- 239000005017 polysaccharide Substances 0.000 claims description 4
- 150000003141 primary amines Chemical class 0.000 claims description 4
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims 3
- 229920002678 cellulose Polymers 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 description 26
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 23
- 238000010790 dilution Methods 0.000 description 22
- 239000012895 dilution Substances 0.000 description 22
- 238000009472 formulation Methods 0.000 description 17
- 230000000694 effects Effects 0.000 description 15
- 230000006870 function Effects 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 14
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 12
- 229960004217 benzyl alcohol Drugs 0.000 description 11
- 239000004094 surface-active agent Substances 0.000 description 11
- 241000282414 Homo sapiens Species 0.000 description 10
- 239000006071 cream Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 0 *C1=C[C@@]2([H])[C@]3([H])CC(=O)O[C@@H](CC)CCCC(O[C@H]4CC[C@H](N(C)C)[C@@H](C)O4)[C@@H](C)C(=O)C3=C[C@@]2([H])[C@]2([H])C[C@H](OC3O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]3OC)C[C@@]12[H] Chemical compound *C1=C[C@@]2([H])[C@]3([H])CC(=O)O[C@@H](CC)CCCC(O[C@H]4CC[C@H](N(C)C)[C@@H](C)O4)[C@@H](C)C(=O)C3=C[C@@]2([H])[C@]2([H])C[C@H](OC3O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]3OC)C[C@@]12[H] 0.000 description 9
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 9
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 9
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 8
- 239000005906 Imidacloprid Substances 0.000 description 8
- 229940056881 imidacloprid Drugs 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 241000517308 Pediculus humanus capitis Species 0.000 description 7
- 239000008367 deionised water Substances 0.000 description 7
- 229910021641 deionized water Inorganic materials 0.000 description 7
- 238000007654 immersion Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 238000011534 incubation Methods 0.000 description 6
- 239000003981 vehicle Substances 0.000 description 6
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 210000003169 central nervous system Anatomy 0.000 description 4
- NLDGJRWPPOSWLC-UHFFFAOYSA-N deca-1,9-diene Chemical compound C=CCCCCCCC=C NLDGJRWPPOSWLC-UHFFFAOYSA-N 0.000 description 4
- 230000001804 emulsifying effect Effects 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 4
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 239000002453 shampoo Substances 0.000 description 4
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 241000517324 Pediculidae Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 241000517305 Pthiridae Species 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 239000006172 buffering agent Substances 0.000 description 3
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 239000003974 emollient agent Substances 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000002917 insecticide Substances 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229960000490 permethrin Drugs 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 3
- 230000003381 solubilizing effect Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 description 2
- JLYXXMFPNIAWKQ-GNIYUCBRSA-N gamma-hexachlorocyclohexane Chemical compound Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl JLYXXMFPNIAWKQ-GNIYUCBRSA-N 0.000 description 2
- JLYXXMFPNIAWKQ-UHFFFAOYSA-N gamma-hexachlorocyclohexane Natural products ClC1C(Cl)C(Cl)C(Cl)C(Cl)C1Cl JLYXXMFPNIAWKQ-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- 210000004919 hair shaft Anatomy 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 229960002809 lindane Drugs 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 210000003689 pubic bone Anatomy 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OQQOAWVKVDAJOI-UHFFFAOYSA-N (2-dodecanoyloxy-3-hydroxypropyl) dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCC OQQOAWVKVDAJOI-UHFFFAOYSA-N 0.000 description 1
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- TYIOVYZMKITKRO-UHFFFAOYSA-N 2-[hexadecyl(dimethyl)azaniumyl]acetate Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)CC([O-])=O TYIOVYZMKITKRO-UHFFFAOYSA-N 0.000 description 1
- GLCFQKXOQDQJFZ-UHFFFAOYSA-N 2-ethylhexyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(CC)CCCC GLCFQKXOQDQJFZ-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 241000790936 Haematopinidae Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 241000255777 Lepidoptera Species 0.000 description 1
- 241001113971 Linognathidae Species 0.000 description 1
- 206010028347 Muscle twitching Diseases 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- GWFGDXZQZYMSMJ-UHFFFAOYSA-N Octadecansaeure-heptadecylester Natural products CCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC GWFGDXZQZYMSMJ-UHFFFAOYSA-N 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 241000322706 Polyplacidae Species 0.000 description 1
- 229920000289 Polyquaternium Polymers 0.000 description 1
- 241000517304 Pthirus pubis Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 102100021227 TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 Human genes 0.000 description 1
- 101710178681 TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 Proteins 0.000 description 1
- 240000004460 Tanacetum coccineum Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- FOLJTMYCYXSPFQ-CJKAUBRRSA-N [(2r,3s,4s,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-(octadecanoyloxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl octadecanoate Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)O[C@@H]1O[C@@]1(COC(=O)CCCCCCCCCCCCCCCCC)[C@@H](O)[C@H](O)[C@@H](CO)O1 FOLJTMYCYXSPFQ-CJKAUBRRSA-N 0.000 description 1
- KJYGRYJZFWOECQ-UHFFFAOYSA-N [2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-(16-methylheptadecanoyloxy)propoxy]propoxy]propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)COCC(O)COC(=O)CCCCCCCCCCCCCCC(C)C KJYGRYJZFWOECQ-UHFFFAOYSA-N 0.000 description 1
- ROVGZAWFACYCSP-MQBLHHJJSA-N [2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(C\C=C/C=C)C(=O)C1 ROVGZAWFACYCSP-MQBLHHJJSA-N 0.000 description 1
- BLPKQJYEQNBXDG-UHFFFAOYSA-N [Na].[Na].OCC1=CC=CC=C1 Chemical compound [Na].[Na].OCC1=CC=CC=C1 BLPKQJYEQNBXDG-UHFFFAOYSA-N 0.000 description 1
- 229940116342 acetylated sucrose distearate Drugs 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 1
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- INDXRDWMTVLQID-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO.OCCCCO INDXRDWMTVLQID-UHFFFAOYSA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 239000003916 calcium stearoyl-2-lactylate Substances 0.000 description 1
- 235000010957 calcium stearoyl-2-lactylate Nutrition 0.000 description 1
- OEUVSBXAMBLPES-UHFFFAOYSA-L calcium stearoyl-2-lactylate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O.CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O OEUVSBXAMBLPES-UHFFFAOYSA-L 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-O carboxymethyl-[3-(dodecanoylamino)propyl]-dimethylazanium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)=O MRUAUOIMASANKQ-UHFFFAOYSA-O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- CRQQGFGUEAVUIL-UHFFFAOYSA-N chlorothalonil Chemical compound ClC1=C(Cl)C(C#N)=C(Cl)C(C#N)=C1Cl CRQQGFGUEAVUIL-UHFFFAOYSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940071160 cocoate Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 210000001520 comb Anatomy 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- WVYSISRGVMAJBR-XXAVUKJNSA-L disodium;3-[2-(2-carboxylatoethoxy)ethyl-[2-[[(z)-octadec-9-enoyl]amino]ethyl]amino]propanoate Chemical compound [Na+].[Na+].CCCCCCCC\C=C/CCCCCCCC(=O)NCCN(CCC([O-])=O)CCOCCC([O-])=O WVYSISRGVMAJBR-XXAVUKJNSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 208000028104 epidemic louse-borne typhus Diseases 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 description 1
- 229940074049 glyceryl dilaurate Drugs 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 description 1
- HJJLDNAELNDBBL-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO.OCCCCCCO HJJLDNAELNDBBL-UHFFFAOYSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 229940075468 lauramidopropyl betaine Drugs 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 229940041033 macrolides Drugs 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- BOUCRWJEKAGKKG-UHFFFAOYSA-N n-[3-(diethylaminomethyl)-4-hydroxyphenyl]acetamide Chemical compound CCN(CC)CC1=CC(NC(C)=O)=CC=C1O BOUCRWJEKAGKKG-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- FWWQKRXKHIRPJY-UHFFFAOYSA-N octadecyl aldehyde Natural products CCCCCCCCCCCCCCCCCC=O FWWQKRXKHIRPJY-UHFFFAOYSA-N 0.000 description 1
- NKBWPOSQERPBFI-UHFFFAOYSA-N octadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC NKBWPOSQERPBFI-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 235000019831 pentapotassium triphosphate Nutrition 0.000 description 1
- ATGAWOHQWWULNK-UHFFFAOYSA-I pentapotassium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [K+].[K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O ATGAWOHQWWULNK-UHFFFAOYSA-I 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- OJTDGPLHRSZIAV-UHFFFAOYSA-N propane-1,2-diol Chemical compound CC(O)CO.CC(O)CO OJTDGPLHRSZIAV-UHFFFAOYSA-N 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- WHFQAROQMWLMEY-UHFFFAOYSA-N propylene dimer Chemical group CC=C.CC=C WHFQAROQMWLMEY-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 229940015367 pyrethrum Drugs 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940070720 stearalkonium Drugs 0.000 description 1
- 229940105131 stearamine Drugs 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 206010061393 typhus Diseases 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/22—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom rings with more than six members
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N51/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds having the sequences of atoms O—N—S, X—O—S, N—N—S, O—N—N or O-halogen, regardless of the number of bonds each atom has and with no atom of these sequences forming part of a heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Definitions
- the present invention relates to compositions and methods for controlling and treating adult lice and nits (or ova) of species of the order of Anoplura, including but not limited to pediculus capitis, pediculus humanus and pthiris pubic, by applying a composition of pediculicides and ovacides in solution to skin and hair, including but not limited to human skin and hair.
- the compositions comprise effective pediculicidal agents and ovacidal agents which are solubilized to promote penetration of the ova. More particularly, the effective pediculicidal agents and ovacidal agents are spinosad, Spinosyn A, Spinosyn D, or combinations thereof.
- Lice present a source of serious health problems worldwide for man and animals. Not only do lice carry a variety of bacteria on their outer surfaces, but in their fecal matter as well. Lice transmit the bacteria to their hosts through puncture wounds which are inflicted during feeding, since lice must feed from their host's blood. Ailments ranging from skin infections to typhus can be traced back to lice infestation.
- Lice belong to the order Anoplura. Specific species that affect human beings include pediculus capitis (head lice), pediculus humanus (body lice) and pthiris pubic (pubic lice). Lice are capable of spreading rapidly. A fertilized female lays about six to eight eggs, or nits, every twenty-four hours. It has been estimated that a single female louse and her daughters could have 112,778 offspring in a period of forty-eight days.
- Pediculus capitis clings to the hair shaft when feeding, mating, and laying eggs. Removal of nits is particularly difficult, as each nit is cemented to a shaft of hair by a glycoprotein glue, acting as a binding cement. Lice eggs themselves are covered by a chitinous sheath which surrounds both the nit and the attached hair shaft.
- Pediculicides such as lindane and various permethrins, have been used in conjunction with shampoos for killing and rinsing out lice.
- Pediculicides such as lindane and various permethrins
- shampoos for killing and rinsing out lice.
- the use of these methods and compositions is not entirely effective in controlling head lice, as some lice often survive the treatment. Indeed, the National Pediculosis Association has reported that twenty to eighty percent of nits survive initial pediculicide treatment, resulting in reinfestation.
- Spinosyn A and Spinosyn D compounds that have been used as insecticides for turf building and ornamental plants may be used for killing lice.
- Spinosyn A and Spinosyn D are components of a fermentation product derived from the bacterium species Saccharopolyspora spinosa. The bacteria decomposes much of the organic matter in soil and the most active metabolites from this fermentation were identified as Spinosyn A and D.
- the chemical structure of spinosad contains two sugar molecules, one located at each end. A tetracyclic ring structure joins the two sugars. This structure is one of a class of compounds called macrolides.
- the chemical structure of spinosyns has the general formula of:
- R is defined as any chemical group which provides pediculicidal and ovacidal properties, most preferably H and CH3.
- the present invention includes a composition comprising an effective amount of one or more agents having pediculicidal and ovacidal properties for adult lice and nits of a specie of order Anoplura in solution.
- Another embodiment of the invention comprises pediculicidal agents and ovacidal agents in solution for adult lice and nits which comprise the chemical structure of:
- the present invention includes a composition comprising a mixture of spinosyn A and spinosyn D in an approximate weight ratio of 85:15,water, methyl vinyl ether/maleic anhydride crosslinked with 1,9 decadiene, propylene glycol, a mixture of cetyl and stearyl alcohols, ceteareth-20, stearalkonium chloride, benzyl alcohol, pentylene glycol, isopropyl alcohol, BHT and sodium hydroxide.
- the present invention includes a method of controlling adults and ova of the species of order Anoplura by topically applying to one or more of skin and hair a composition comprising an effective amount of one or more agents having pediculicidal and ovacidal properties for adult lice and nits of a specie of order Anoplura in solution.
- the pediculicidal and ovacidal properties include the abilities to control adult lice and lice ova (or nits).
- the present invention includes a method of controlling adults and ova of the species of order Anoplura by topically applying to one or more of skin and hair a composition comprising an effective amount of one or more agents having pediculicidal and ovacidal properties for adult lice and nits of a specie of order Anoplura in solution, which agents comprise the chemical structure of:
- the present invention includes a method of controlling adults and ova of the species of order Anoplura by topically applying to one or more of skin and hair a composition comprising a mixture of spinosyn A and spinosyn D in an approximate weight ratio of 80:20, water, methyl vinyl ether/maleic anhydride crosslinked with 1,9 decadiene, propylene glycol, a mixture of cetyl and stearyl alcohols, ceteareth-20, stearalkonium chloride, benzyl alcohol, pentylene glycol, isopropyl alcohol, BHT and sodium hydroxide.
- Another embodiment of the present invention includes a method of controlling adults and ova of the species of order Anoplura by topically applying to one or more of skin and hair a composition comprising about 1 to about 2.2% of Spinosyn A & D in an approximate weight ratio of 85:15, about 44% deionized water, about 1.1 Stabileze QM, about 3% propylene glycol, about 3% cetostearyl alcohol NF, about 0.9% Ceteareth-20, about 4.17% stearalkonium chloride (or Ammonyx 4 (18%)), about 10% benzyl alcohol, about 6% hexylene glycol, about 4% pentylene glycol, about 20% isoproyl alcohol, about 0.1% BHT and about 1.2 to about 1.9% sodium hydroxide (10% solution).
- a further separate embodiment of the present invention is a method for solubilizing agents having pediculicidal and ovacidal properties comprising combining one or more solvents and an effective amount of one or more agents having pediculicidal and ovacidal properties; wherein the agents comprise a chemical structure of:
- the present invention relates to a composition comprising an effective amount of agents with pediculicidal and ovacidal properties in a cosmetically elegant solution or emulsion, including but not limited to imidacloprid, spinosad, a spinosyn, Spinosyn A, Spinosyn D, any component produced from the Saccharopolyspora spinosa species or combinations. Additionally, the present invention includes the method of applying a pediculicide and ovacide composition in solution to hair or skin for the control of adults and nits of a specie of the order Anoplura.
- Spinosyn A and Spinosyn D are also known as A83543A and A83543D respectively. Both Spinosyn A and Spinosyn D are the major components of a fermentation product known as A83543. This fermentation product, A83543, is produced by the species Saccharopolyspora spinosa.
- an effective amount refers to an amount of imidacloprid, spinosad, spinosyn, Spinosyn A, Spinosyn D or a combination thereof sufficient to decrease the number of live lice and viable nits, i.e. eggs.
- the effective amount can typically range from greater than about 0% to about 10%, preferably, about 0.5% to about 5%. (All percentages in this disclosure are weight percentages.)
- skin refers to that of an animal, preferably a mammal, most preferably a human. Skin that would be commonly prone to nits includes that of the scalp, body, and pubis areas.
- to control is to reduce the number of viable nits and live lice.
- the extent of reduction accomplished by the composition depends upon the application rate of the composition, the choice of imidacloprid, spinosad, spinosyn, Spinosyn A, Spinosyn D, any component produced from the Saccharopolyspora spinosa species and a combination thereof, and the species of Anoplura targeted.
- the order Anoplura includes the following families: echniophtudidae, enderleinellidae, haematopinidae, linognathidae, pecaroecidae, pediculidae, polyplacidae, and pthiridae.
- species in the order Anoplura include, but are not limited to pediculus humanus, pediculus capitis, and pthiris pubis. These three species are known more commonly as the body louse, head louse, and pubic louse.
- solvent refers to solvents capable of solubilizing the pediculicides and ovacides, preferably in the minimum amount required to solubilize the pediculicides and ovacides, preferably about 3% propylene glycol, about 10% benzyl alcohol, about 6 % h exylene g lycol, about 4 % p entylene g lycol, and about 20% isopropyl alcohol.
- solubilizing agents include, but are not limited to, glycols, for example, propylene glycol, polyethylene glycol, dipropylene glycol, pentylene glycol, and methoxypolyethylene glycol, hexylene glycol, butylene glycol; benzyl alcohol; isopropyl alcohol; preferably penetylene glycol; combinations of pentylene glycol, benzyl alcohol and isopropyl alcohol, either with or without one of the following: hexylene glycol, butylene glycol, dipropylene glycol, methoxypolyethylene glycol or propylene glycol; or combinations of hexylene glycol, butylene glycol, benzyl alcohol and isopropyl alcohol (“Solvent Matrices”).
- glycols for example, propylene glycol, polyethylene glycol, dipropylene glycol, pentylene glycol, and methoxypolyethylene glycol, hexylene glycol, butylene glycol
- Solvent Matrices are capable of solubilizing poorly soluble drugs, including but not limited to imidacloprid, spinosad, spinosyn, spinosyn A, spinosyn D, any component produced by the Saccharopolyspora spinosa species and a combination thereof. These Solvent Matrices have the additional function of aiding in the penetration of the ova of the louse.
- compositions of this invention comprise an effective amount of pediculicidal agents and ovacidal agents in solution, used for controlling lice and its ova.
- the solvents are beneficial because they solubilize the pediculicidal agents and o vacidal agents, and also p romote the penetration of the ova so that the ovacidal agents are highly effective. Without being bound by a mechanism, the present invention is believed to better penetrate lice and its ova. Additionally, the compositions of this invention are cosmetically elegant.
- the preferred solvents are benzyl alcohol, pentylene glycol, isopropyl alcohol, hexylene glycol, butylene glycol, dipropylene glycol and combinations thereof.
- the pediculicidal agents and ovacidal agents may be, including but not limited to imidacloprid, spinosad, spinosyn, S pinosyn A, S pinosyn D, any c omponent produced from the Saccharopolyspora spinosa species or a combination thereof.
- the preferred pediculicidal agent and ovacidal agent is a combination of Spinosyn A and Spinosyn D in a weight ratio of 85/15 or 80/20.
- compositions disclosed in this patent have an improved solubility of pediculicides and ovacides, including but not limited to imidacloprid, spinosad, spinosyn, Spinosyn A, Spinosyn D, any component produced from the Saccharopolyspora spinosa species or a combination thereof, which yields a more effective pediculicide and ovacide for the specie of the order of Anoplura.
- Specific species that affect human beings include pediculus capitis (head lice), pediculus humanus (body lice) and pthiris pubic (pubic lice).
- the pediculicides and ovacides are present in a composition with solvents and stabilizers.
- the solvents may help promote the penetration of the composition into the ova in order to act like a ovacide, in addition to being a pediculicide.
- the invention features a composition comprising an effective amount of one or more pediculicidal and ovacidal properties, which may include but is not limited to imidacloprid, spinosad, spinosyn, Spinosyn A, Spinosyn D, any component produced from the Saccharopolyspora spinosa species or a combination thereof; water; benzyl alcohol; hexylene glycol; pentylene glycol; butylene glycol; dipropylene glycol; isopropyl alcohol; and a n on-acrylic stabilizer, for example, a c o-polymer of methyl vinyl ether/maleic anhydride cross-linked with 1,9-decadiene.
- This composition is beneficial because it is capable of solubilizing the pediculicidal and/or ovacidal agents, which results in high mortality of adult lice and their ova.
- the solubilizing agents of the composition may include glycols, for example, propylene glycol, polyethylene glycol, dipropylene glycol, pentylene glycol, and methoxypolyethylene glycol, hexylene glycol, butylene glycol; benzyl alcohol; isopropyl alcohol; preferably penetylene glycol; combinations of pentylene glycol, benzyl alcohol and isopropyl alcohol, either with or without one of the following: hexylene glycol, butylene glycol, dipropylene glycol, methoxypolyethylene glycol or propylene glycol; or combinations of hexylene glycol, butylene glycol, benzyl alcohol and isopropyl alcohol.
- glycols for example, propylene glycol, polyethylene glycol, dipropylene glycol, pentylene glycol, and methoxypolyethylene glycol, hexylene glycol, butylene glycol; benzyl alcohol; isopropyl
- the present invention also relates to a composition
- a composition comprising an effective amount of one or more pediculicides and ovacides for nits and adult lice (collectively “Lice”) of a specie of the order Anoplura and a solubilizing agent.
- the pediculicides and ovacides are ingredients which control the Lice, including but not limited to any component produced by the Saccharopolyspora spinosa species, imidacloprid (also known as NTN 33893, which is a proprietary chemical of Bayer AG), spinosad, spinosyn, Spinosyn A and Spinosyn D, and a combination thereof, preferably a mixture of Spinosyn A and Spinosyn D in an approximate weight ratio of 80:20.
- the preferable amount of stabilizers is between about 0.5 to about 1.5%.
- cleansing surfactants is one or more compounds used for skin and/or hair cleaning, and the cleansing surfactants are used in an amount which produces the desired function provided that the amount does not effect the stability of the solution. These compounds can also serve as cosmetic emulsifiers. Classes of compounds include soaps and fatty acids/alkali combinations. Examples include, but are not limited to, ammonium lauryl sulfate, ammonium laureth sulfate, sodium lauryl sulfate, sodium laureth sulfate. For a more complete listing of cleansing surfactants, herein incorporated by reference, see CFTA Dictionary 1789-1795.
- emulsifying surfactants is one or more compounds that reduce surface tension and the emulsifying surfactants are used in an amount which produces the d esired function provided that the amount does not effect the stability of the solution. They create barriers around droplets to prevent them from coalescing.
- Emulsifiers could be, but are not limited to oil-in-water emulsifiers, water-in-oil emulsifiers, water-in-oil-in-water emulsifiers, oil-in-water-in-oil emuls, silicone-in-water emulsifiers, and water-in-silicone emulsifiers.
- Examples include, but are not limited to, glyceryl trioleate, acetylated sucrose distearate, sorbitan trioleate, polyoxyethylene (1) monostearate, glycerol monooleate, sucrose distearate, polyethylene glycol (50) monostearate, octyl phenoxypoly (ethyleneoxy) ethanol, deacylerin p enta-isostearate, s orbitan s esquioleate, h ydroxylated lanolin, lanolin, triglyceryl diisostearate, polyoxyethylene (2) oleyl ether, calcium stearoyl-2-lactylate, cetearyl glucoside, methyl glucoside sesquistearate, sorbitan monopalmitate, methoxy polyethylene glycol-22/dodecyl glycol copolymer, polyethylene glycol-45/dodecyl glycol copolymer, polyethylene glycol 400
- foam-boosting surfactants is one or more compounds that have the ability to either generate or stabilize foams and the foam-boosting surfactants are used in an amount which produces the desired function provided that the amount does not effect the stability of the solution. They generally increase the surface viscosity of the vehicle surrounding the bubbles.
- foam-boosting surfactants include, but are not limited to, cocamidoethyl betaine, cetyl betaine, disodium cetearyl sulfosuccinate, disodium oleoamphodipropionate, lauramide DEA, lauramidopropyl betaine. See also CTFA Dictionary, 1803-1804.
- emollient skin conditioning agents is one or more compounds that soften and smooth the skin and the emollient skin conditioning agents are used in an amount which produces the desired function provided that the amount does not effect the stability oft he solution. These compounds achieve this effect lubricating the skin surface, encouraging skin water retention, and altering product textures. Examples include, but are not limited to, octyl hydroxystearate, lanolin, capric/caprylic triglyceride, cetyl palmitate, cetyl alcohol, isopropyl isostearate, glyceryl dilaurate, isopropyl myristate, palm alcohol, and sucrose cocoate. See also CTFA Dictionary 1768-1773.
- humectants is one or more compounds that prevent the skin from losing moisture and the humectants are used in an amount which produces the desired function provided that the amount does not effect the stability of the solution. Examples include, but are not limited to, glycerin, glucose, honey, lactic acid, polyethylene glycol, propylene glycol, sorbitol, sucrose, and trehalose. See also CTFA Dictionary 1773-1774.
- buffering agents is one or more compounds that can maintain a desired pH in an aqueous environment and the buffering agents are used in an amount which produces the desired function provided that the amount does not effect the stability oft he solution. Examples include, but are not limited to, boric acid, citric acid, lactic acid, fumaric acid, phosphoric acid, and salts thereof. See also CTFA Dictionary 1733-1734.
- chelating agents is one or more compounds that can complex and subsequently inactivate ions in the formulation and the chelating agents are used in an amount which produces the desired function provided that the amount does not effect the stability of the solution. Examples include, citric acid, disodium edetate, pentapotassium triphosphate, and phytic acid. See also CTFA Dictionary 1734-1735.
- preservatives is one or more compounds that prevent or reduce or slow down microbial growth and the preservatives are used in an amount which produces the desired function provided that the amount does not effect the stability of the solution. Examples include, but are not limited to, benzoic acid, butylparaben, ethylparaben, propylparaben, methylparaben, sorbic acid, phenoxyethanol, and triclosan. See CTFA Dictionary 1765-1766.
- pH Adjusters are also present in some embodiments of the invention and the pH Adjusters are used in an amount which produces the desired function provided that the amount does not effect the stability of the solution.
- pH adjuster are acids or bases that can be used to adjust the pH of the finished product to the desired level. Examples include, but are not limited to, acetic acid, ammonia, citric acid, ethanolamine, formic acid, oxalic acid, potassium hydroxide, sodium hydroxide, and triethanolamine. See also Wenniger and McEwen, eds., 2 International Cosmetic Ingredient Dictionary and Handbook 1764 (2000 ed.) (hereinafter “CFTA Dictionary”). All cited references in this application are herein incorporated by reference.
- an embodiment of the invention may include one or more moisturizers, preferably propylene glycol and the moisturizers are used in an amount which produces the desired function provided that the amount does not effect the stability of the solution.
- emulsifying agents may be desirable, preferably Ceteareth-20, manufactured by Promateen Chemicals Inc., which is a polyethylene glycol ether of cetearyl alcohol. Ceteareth-20 has 20 moles of ethylene oxide which is added to the non-ionic surfactant to increase its water solubility.
- the preferred one is a mixture of cetyl and stearyl alcohols, sold by Croda Inc. under the name Cetearyl alcohol.
- antioxidants may be included in the formulation and the antioxidants are used in an amount which produces the desired function provided that the amount does not effect the stability of the solution.
- Antioxidants include, but are not limited to free radical scavengers and reducing agents such as, acetyl cysteine, ascorbic acid, butylated hydroxytoluene, green tea extract, caffeic acid, cysteine, tocopherol, ubiquinone, and propyl gallate, preferably butylated hydroxytoluene (“BHT”). See CFTA Dictionary 1727.
- hair conditioning agents or “conditioning agents” are compounds that can alter the texture, appearance, styling, or feel of the hair and the conditioning agents are used in an amount which produces the desired function provided that the amount does not effect the stability of the solution. Examples include, but are not limited to, alanine, arginine, biotin, calcium panthothenate, dimethicone, cyclomethicone, hydrolyzed plant protein, and polyquaterniums, preferably stearalkonium chloride, sold under the name Ammonyx-4 by Stepan Company. See CFTA Dictionary 1752-1759.
- compositions in addition to the pediculicides, ovacides and Solvent Matrices, these compositions can further comprise adjuvants and the adjuvants are used in an amount which produces the desired function provided that the amount does not effect the stability oft he solution.
- adjuvants include, but are not limited to vehicles, stabilizers, moisturizers, cleansing surfactants, emulsifying surfactants, emulsifying stabilizers, foam-boosting surfactants, emollient skin conditioning agents, humectants, hair conditioning agents, buffering agents, pH adjusters, chelating agents, antioxidants, preservatives, botanical extracts, fragrances, and dyes.
- the composition includes one or more pediculicide and ovacide, the Solvent Matrices, and one or more stabilizers to prevent physical separation of the formulation (“Stabilizers”).
- Stabileze QM and Stabileze 06 are benzene-free copolymers of methyl vinyl ether/maleic anhydride crosslinked with 1,9-decadiene.
- the INCI name for Stabileze 06 and Stabileze QM is PVM/MA Decadiene crosspolymers.
- Stabileze 06 has a particle size of ⁇ 850 ⁇ .
- Stabileze QM has a particle size of ⁇ 75 ⁇ . Since Stabileze QM has a smaller particle size, it may be dispersed faster than Stabileze 06 and may be more rapidly converted to a gel.
- a neutralizer of the stabilizer may be required to neutralize the formulation to an approximate pH of 5.5 in order to allow thickening of the formulation.
- a preferred neutralizer is sodium hydroxide.
- Stabilizers may also include but are not limited to acrylates/aminoacrylates C10-30 Alkyl PEG-20 Itaconate copolymer, long chain acyl derivatives (including but not limited to ethylene glycol distearate and ethylene glycol monostearate), alkanoamides (including but not limited to cocamide MEA), esters of long chain fatty acids (including but not limited to stearyl stearate), alkyl dimethylamine oxides, methylcellulose, hydroxybutyl methylcellulose, hydroxypropylcellulose, hydroxypropyl methylcellulose, hydroxyethyl cellulose, distearyl phthalic amide (e.g.
- Stephan SAB-2 di(hydrogenated) tallow phthalic amide
- primary amines with a fatty alkyl moiety of at least 16 carbons including but not limited to palmitate amine or stearamine
- polyacrylic acids including but not limited to Xanthan Gum
- colloidal clays including but not limited to benzyl dimethyl hydrogenated tallow ammonium montmorillonite
- colloidal silica including but not limited to benzyl dimethyl hydrogenated tallow ammonium montmorillonite
- One of the preferred embodiments is in the form of a conditioner or cream rinse for human hair or animal hair.
- Hair conditioning agents may be included in the formulation.
- compositions can be administered topically to an animal, by the direct laying on or spreading of the composition on the skin or hair, preferably of a mammal, most preferably of a human.
- compositions useful in the subject invention involve formulations suitable for topical application to mammalian skin or hair. Additionally, the compositions may be made into a wide variety of product types. These include, but are not limited to solutions, aerosols, lotions, creams, gels, sticks, ointments, pastes, cream rinses, shampoos, and body washes.
- the preferred embodiments are cream rinses, conditioners and shampoos.
- Vehicles include but are not limited to water, propylene glycol, butylene glycol, ethanol, isopropanol, silicones.
- the vehicle is water.
- Dilution 1 contained 8.62% conservee SC, 15% isopropanol, 10% propylene carbonate, and 53.45% deionized water. Dilution 1 resulted in a 1% Spinosad concentration.
- Dilution 2 contained 21.55% conservee SC, 15% isopropanol, 10% propylene carbonate, and 66.38% deionized water. Dilution 2 resulted in a 2.5% Spinosad concentration.
- Dilution 3 contained 43.10% conservee SC, 15% isopropanol, 10% propylene carbonate, and 31.9% deionized water. Dilution 3 resulted in a 5% Spinosad concentration.
- the ovacidal assay was conducted at ambient room temperature (25° to 35° C.) and humidity (70-90% RH). Ten hairs with viable eggs were sandwiched between small adhesive labels, allowing 2 cm of the hairs to protrude, with the eggs aligned at the distal end. Immediately prior to testing, the dilutions were shaken thoroughly and dispensed into clean glass vials. The eggs were completely immersed in the formulations for ten minutes. Following immersion, the hair and eggs were rinsed in a gentle stream of filtered water from a squeeze bottle to simulate natural shower conditions. They were allowed to air dry for 30 minutes before being placed in capped vials for incubation at 28° to 32° C., RH 70-90%.
- Ovacidal activity was recorded as number of eggs tested, number of eggs hatched, number of eggs not hatched, and number of eggs stillborn. What was meant by “stillborn” referred to the nymphs that reach maturity, are able to lift the operculum, or cap of the egg, but are unable to fully emerge. These stillborn eggs were considered non-viable.
- Table 2 shows the ovacidal activity for 10-minute immersion on three successive days followed by two week incubation.
- Double Exposure means that the ova were exposed to the formulation for 10 minutes on Day 1 and Day 4.
- Ovacidal Rate means the percent of louse ova unhatched after a 14 day incubation period.
- compositions of this invention are not irritants to human skin.
- Draize sensitization study (repeat insult patch test) using a placebo (described in the table above) for one of the vehicles. 100 human subjects were involved for 5 weeks. No subject showed sensitization when the vehicle was applied to the skin.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to compositions and methods for administering compositions in solutions for killing adult lice and the ova comprising water, PVM/MA Decadiene crosspolymers, propylene glycol, a mixture of cetyl and stearyl alcohols, Ceteareth-20; stearalkonium chloride; benzyl alcohol; hexylene glycol; pentylene glycol, isopropyl alcohol; a mixture of spinosyn A and spinosyn D in a weight ratio of 80:20, BHT; and sodium hydroxide.
Description
- This application is a divisional application of U.S. Ser. No. 10/230,460, filed Aug. 29, 2002, which is a divisional application of U.S. Ser. No. 09/841,715, filed Apr. 25, 2001.
- The present invention relates to compositions and methods for controlling and treating adult lice and nits (or ova) of species of the order of Anoplura, including but not limited topediculus capitis, pediculus humanus and pthiris pubic, by applying a composition of pediculicides and ovacides in solution to skin and hair, including but not limited to human skin and hair. The compositions comprise effective pediculicidal agents and ovacidal agents which are solubilized to promote penetration of the ova. More particularly, the effective pediculicidal agents and ovacidal agents are spinosad, Spinosyn A, Spinosyn D, or combinations thereof.
- Lice present a source of serious health problems worldwide for man and animals. Not only do lice carry a variety of bacteria on their outer surfaces, but in their fecal matter as well. Lice transmit the bacteria to their hosts through puncture wounds which are inflicted during feeding, since lice must feed from their host's blood. Ailments ranging from skin infections to typhus can be traced back to lice infestation.
- Lice belong to the order Anoplura. Specific species that affect human beings includepediculus capitis (head lice), pediculus humanus (body lice) and pthiris pubic (pubic lice). Lice are capable of spreading rapidly. A fertilized female lays about six to eight eggs, or nits, every twenty-four hours. It has been estimated that a single female louse and her daughters could have 112,778 offspring in a period of forty-eight days.
-
- Various methods and compositions have been used to remove lice, for example mechanical removal with combs and chemical removal with insecticides (known as pediculicides). Pediculicides, such as lindane and various permethrins, have been used in conjunction with shampoos for killing and rinsing out lice. However, as noted in the prior art, the use of these methods and compositions is not entirely effective in controlling head lice, as some lice often survive the treatment. Indeed, the National Pediculosis Association has reported that twenty to eighty percent of nits survive initial pediculicide treatment, resulting in reinfestation.
- In the prior art, pyrethrum, permethrin, and lindane pesticides, all work as central nervous system toxins on lice. Their effectiveness depends on their ability to reach the functioning central nervous system on lice. Unfortunately, nits do not develop a functioning central nervous system until they are between three and four days old, during an average incubation period of approximately ten days. As a result, only sixty to seventy percent of nits treated can be killed upon application of one of these pediculicides.
- Moreover, recently, lice may have begun to develop resistance to current pediculicides. For example, resistance has already been documented in Europe, United States and Israel. Thus, a new active to kill lice and their eggs is desirable.
- It has been discovered that Spinosyn A and Spinosyn D, compounds that have been used as insecticides for turf building and ornamental plants may be used for killing lice. Spinosyn A and Spinosyn D are components of a fermentation product derived from the bacterium speciesSaccharopolyspora spinosa. The bacteria decomposes much of the organic matter in soil and the most active metabolites from this fermentation were identified as Spinosyn A and D.
-
- R is defined as any chemical group which provides pediculicidal and ovacidal properties, most preferably H and CH3.
- It is known that Spinosyn A and Spinosyn D are useful as insecticides against Lepidoptera and Diptera species. Spinosyns have been used in a pediculicidal shampoo. The prior art does not teach the use of spinosyns in solution.
- Known pediculicides have been noted to be ineffective on killing ova. Thus, the use of these pediculicides results in a reinfestation of the hair or skin as soon as the ova hatch, since the treatment was ineffective in controlling and killing the ova. A need has arisen to develop an effective treatment for both adult lice and their ova in a cosmetically elegant form.
- The present invention includes a composition comprising an effective amount of one or more agents having pediculicidal and ovacidal properties for adult lice and nits of a specie of order Anoplura in solution.
-
- In another embodiment, the present invention includes a composition comprising a mixture of spinosyn A and spinosyn D in an approximate weight ratio of 85:15,water, methyl vinyl ether/maleic anhydride crosslinked with 1,9 decadiene, propylene glycol, a mixture of cetyl and stearyl alcohols, ceteareth-20, stearalkonium chloride, benzyl alcohol, pentylene glycol, isopropyl alcohol, BHT and sodium hydroxide.
- The present invention includes a method of controlling adults and ova of the species of order Anoplura by topically applying to one or more of skin and hair a composition comprising an effective amount of one or more agents having pediculicidal and ovacidal properties for adult lice and nits of a specie of order Anoplura in solution. The pediculicidal and ovacidal properties include the abilities to control adult lice and lice ova (or nits).
- The present invention includes a method of controlling adults and ova of the species of order Anoplura by topically applying to one or more of skin and hair a composition comprising an effective amount of one or more agents having pediculicidal and ovacidal properties for adult lice and nits of a specie of order Anoplura in solution, which agents comprise the chemical structure of:
- The present invention includes a method of controlling adults and ova of the species of order Anoplura by topically applying to one or more of skin and hair a composition comprising a mixture of spinosyn A and spinosyn D in an approximate weight ratio of 80:20, water, methyl vinyl ether/maleic anhydride crosslinked with 1,9 decadiene, propylene glycol, a mixture of cetyl and stearyl alcohols, ceteareth-20, stearalkonium chloride, benzyl alcohol, pentylene glycol, isopropyl alcohol, BHT and sodium hydroxide.
- Another embodiment of the present invention includes a method of controlling adults and ova of the species of order Anoplura by topically applying to one or more of skin and hair a composition comprising about 1 to about 2.2% of Spinosyn A & D in an approximate weight ratio of 85:15, about 44% deionized water, about 1.1 Stabileze QM, about 3% propylene glycol, about 3% cetostearyl alcohol NF, about 0.9% Ceteareth-20, about 4.17% stearalkonium chloride (or Ammonyx 4 (18%)), about 10% benzyl alcohol, about 6% hexylene glycol, about 4% pentylene glycol, about 20% isoproyl alcohol, about 0.1% BHT and about 1.2 to about 1.9% sodium hydroxide (10% solution).
- A further separate embodiment of the present invention is a method for solubilizing agents having pediculicidal and ovacidal properties comprising combining one or more solvents and an effective amount of one or more agents having pediculicidal and ovacidal properties; wherein the agents comprise a chemical structure of:
- The present invention relates to a composition comprising an effective amount of agents with pediculicidal and ovacidal properties in a cosmetically elegant solution or emulsion, including but not limited to imidacloprid, spinosad, a spinosyn, Spinosyn A, Spinosyn D, any component produced from theSaccharopolyspora spinosa species or combinations. Additionally, the present invention includes the method of applying a pediculicide and ovacide composition in solution to hair or skin for the control of adults and nits of a specie of the order Anoplura.
- Spinosyn A and Spinosyn D are also known as A83543A and A83543D respectively. Both Spinosyn A and Spinosyn D are the major components of a fermentation product known as A83543. This fermentation product, A83543, is produced by the speciesSaccharopolyspora spinosa.
- What is meant by “an effective amount” refers to an amount of imidacloprid, spinosad, spinosyn, Spinosyn A, Spinosyn D or a combination thereof sufficient to decrease the number of live lice and viable nits, i.e. eggs. The effective amount can typically range from greater than about 0% to about 10%, preferably, about 0.5% to about 5%. (All percentages in this disclosure are weight percentages.)
- When “effective amount” refers to solvents, solubilizing agents or solutions, the term means that the solvents solubilize the pediculicidal agents and ovacidal agents and also that the solution has a concentration that effectively controls the lice and ova.
- What is meant by “skin” refers to that of an animal, preferably a mammal, most preferably a human. Skin that would be commonly prone to nits includes that of the scalp, body, and pubis areas.
- What is meant by “to control” is to reduce the number of viable nits and live lice. The extent of reduction accomplished by the composition depends upon the application rate of the composition, the choice of imidacloprid, spinosad, spinosyn, Spinosyn A, Spinosyn D, any component produced from theSaccharopolyspora spinosa species and a combination thereof, and the species of Anoplura targeted.
- The order Anoplura includes the following families: echniophtiriidae, enderleinellidae, haematopinidae, linognathidae, pecaroecidae, pediculidae, polyplacidae, and pthiridae. Examples of species in the order Anoplura include, but are not limited topediculus humanus, pediculus capitis, and pthiris pubis. These three species are known more commonly as the body louse, head louse, and pubic louse.
- What is meant by “solubilizing agent” or “solvent” refers to solvents capable of solubilizing the pediculicides and ovacides, preferably in the minimum amount required to solubilize the pediculicides and ovacides, preferably about 3% propylene glycol, about 10% benzyl alcohol, about 6 % h exylene g lycol, about 4 % p entylene g lycol, and about 20% isopropyl alcohol. Examples of solubilizing agents include, but are not limited to, glycols, for example, propylene glycol, polyethylene glycol, dipropylene glycol, pentylene glycol, and methoxypolyethylene glycol, hexylene glycol, butylene glycol; benzyl alcohol; isopropyl alcohol; preferably penetylene glycol; combinations of pentylene glycol, benzyl alcohol and isopropyl alcohol, either with or without one of the following: hexylene glycol, butylene glycol, dipropylene glycol, methoxypolyethylene glycol or propylene glycol; or combinations of hexylene glycol, butylene glycol, benzyl alcohol and isopropyl alcohol (“Solvent Matrices”). These Solvent Matrices are capable of solubilizing poorly soluble drugs, including but not limited to imidacloprid, spinosad, spinosyn, spinosyn A, spinosyn D, any component produced by theSaccharopolyspora spinosa species and a combination thereof. These Solvent Matrices have the additional function of aiding in the penetration of the ova of the louse.
- The compositions of this invention comprise an effective amount of pediculicidal agents and ovacidal agents in solution, used for controlling lice and its ova. The solvents are beneficial because they solubilize the pediculicidal agents and o vacidal agents, and also p romote the penetration of the ova so that the ovacidal agents are highly effective. Without being bound by a mechanism, the present invention is believed to better penetrate lice and its ova. Additionally, the compositions of this invention are cosmetically elegant. The preferred solvents are benzyl alcohol, pentylene glycol, isopropyl alcohol, hexylene glycol, butylene glycol, dipropylene glycol and combinations thereof. More particularly, the pediculicidal agents and ovacidal agents may be, including but not limited to imidacloprid, spinosad, spinosyn, S pinosyn A, S pinosyn D, any c omponent produced from theSaccharopolyspora spinosa species or a combination thereof. The preferred pediculicidal agent and ovacidal agent is a combination of Spinosyn A and Spinosyn D in a weight ratio of 85/15 or 80/20.
- The compositions disclosed in this patent have an improved solubility of pediculicides and ovacides, including but not limited to imidacloprid, spinosad, spinosyn, Spinosyn A, Spinosyn D, any component produced from theSaccharopolyspora spinosa species or a combination thereof, which yields a more effective pediculicide and ovacide for the specie of the order of Anoplura. Specific species that affect human beings include pediculus capitis (head lice), pediculus humanus (body lice) and pthiris pubic (pubic lice).
- More particularly, the pediculicides and ovacides are present in a composition with solvents and stabilizers. The solvents may help promote the penetration of the composition into the ova in order to act like a ovacide, in addition to being a pediculicide.
- In one embodiment, the invention features a composition comprising an effective amount of one or more pediculicidal and ovacidal properties, which may include but is not limited to imidacloprid, spinosad, spinosyn, Spinosyn A, Spinosyn D, any component produced from theSaccharopolyspora spinosa species or a combination thereof; water; benzyl alcohol; hexylene glycol; pentylene glycol; butylene glycol; dipropylene glycol; isopropyl alcohol; and a n on-acrylic stabilizer, for example, a c o-polymer of methyl vinyl ether/maleic anhydride cross-linked with 1,9-decadiene. This composition is beneficial because it is capable of solubilizing the pediculicidal and/or ovacidal agents, which results in high mortality of adult lice and their ova.
- In one embodiment, the solubilizing agents of the composition may include glycols, for example, propylene glycol, polyethylene glycol, dipropylene glycol, pentylene glycol, and methoxypolyethylene glycol, hexylene glycol, butylene glycol; benzyl alcohol; isopropyl alcohol; preferably penetylene glycol; combinations of pentylene glycol, benzyl alcohol and isopropyl alcohol, either with or without one of the following: hexylene glycol, butylene glycol, dipropylene glycol, methoxypolyethylene glycol or propylene glycol; or combinations of hexylene glycol, butylene glycol, benzyl alcohol and isopropyl alcohol.
- The present invention also relates to a composition comprising an effective amount of one or more pediculicides and ovacides for nits and adult lice (collectively “Lice”) of a specie of the order Anoplura and a solubilizing agent. The pediculicides and ovacides are ingredients which control the Lice, including but not limited to any component produced by theSaccharopolyspora spinosa species, imidacloprid (also known as NTN 33893, which is a proprietary chemical of Bayer AG), spinosad, spinosyn, Spinosyn A and Spinosyn D, and a combination thereof, preferably a mixture of Spinosyn A and Spinosyn D in an approximate weight ratio of 80:20. The preferable amount of stabilizers is between about 0.5 to about 1.5%.
- What is meant by “cleansing surfactants” is one or more compounds used for skin and/or hair cleaning, and the cleansing surfactants are used in an amount which produces the desired function provided that the amount does not effect the stability of the solution. These compounds can also serve as cosmetic emulsifiers. Classes of compounds include soaps and fatty acids/alkali combinations. Examples include, but are not limited to, ammonium lauryl sulfate, ammonium laureth sulfate, sodium lauryl sulfate, sodium laureth sulfate. For a more complete listing of cleansing surfactants, herein incorporated by reference, seeCFTA Dictionary 1789-1795.
- What is meant by “emulsifying surfactants” is one or more compounds that reduce surface tension and the emulsifying surfactants are used in an amount which produces the d esired function provided that the amount does not effect the stability of the solution. They create barriers around droplets to prevent them from coalescing. Emulsifiers could be, but are not limited to oil-in-water emulsifiers, water-in-oil emulsifiers, water-in-oil-in-water emulsifiers, oil-in-water-in-oil emulsifiers, silicone-in-water emulsifiers, and water-in-silicone emulsifiers. Examples include, but are not limited to, glyceryl trioleate, acetylated sucrose distearate, sorbitan trioleate, polyoxyethylene (1) monostearate, glycerol monooleate, sucrose distearate, polyethylene glycol (50) monostearate, octyl phenoxypoly (ethyleneoxy) ethanol, deacylerin p enta-isostearate, s orbitan s esquioleate, h ydroxylated lanolin, lanolin, triglyceryl diisostearate, polyoxyethylene (2) oleyl ether, calcium stearoyl-2-lactylate, cetearyl glucoside, methyl glucoside sesquistearate, sorbitan monopalmitate, methoxy polyethylene glycol-22/dodecyl glycol copolymer, polyethylene glycol-45/dodecyl glycol copolymer, polyethylene glycol 400 distearate and glyceryl stearate, cetyl phosphate, potassium cetyl phosphate. See alsoCTFA Dictionary 1796-1803.
- What is meant by “foam-boosting surfactants” is one or more compounds that have the ability to either generate or stabilize foams and the foam-boosting surfactants are used in an amount which produces the desired function provided that the amount does not effect the stability of the solution. They generally increase the surface viscosity of the vehicle surrounding the bubbles. Examples of foam-boosting surfactants include, but are not limited to, cocamidoethyl betaine, cetyl betaine, disodium cetearyl sulfosuccinate, disodium oleoamphodipropionate, lauramide DEA, lauramidopropyl betaine. See alsoCTFA Dictionary, 1803-1804.
- What is meant by “emollient skin conditioning agents” is one or more compounds that soften and smooth the skin and the emollient skin conditioning agents are used in an amount which produces the desired function provided that the amount does not effect the stability oft he solution. These compounds achieve this effect lubricating the skin surface, encouraging skin water retention, and altering product textures. Examples include, but are not limited to, octyl hydroxystearate, lanolin, capric/caprylic triglyceride, cetyl palmitate, cetyl alcohol, isopropyl isostearate, glyceryl dilaurate, isopropyl myristate, palm alcohol, and sucrose cocoate. See alsoCTFA Dictionary 1768-1773.
- What is meant by “humectants” is one or more compounds that prevent the skin from losing moisture and the humectants are used in an amount which produces the desired function provided that the amount does not effect the stability of the solution. Examples include, but are not limited to, glycerin, glucose, honey, lactic acid, polyethylene glycol, propylene glycol, sorbitol, sucrose, and trehalose. See alsoCTFA Dictionary 1773-1774.
- What is meant by “buffering agents” is one or more compounds that can maintain a desired pH in an aqueous environment and the buffering agents are used in an amount which produces the desired function provided that the amount does not effect the stability oft he solution. Examples include, but are not limited to, boric acid, citric acid, lactic acid, fumaric acid, phosphoric acid, and salts thereof. See alsoCTFA Dictionary 1733-1734.
- What is meant by “chelating agents” is one or more compounds that can complex and subsequently inactivate ions in the formulation and the chelating agents are used in an amount which produces the desired function provided that the amount does not effect the stability of the solution. Examples include, citric acid, disodium edetate, pentapotassium triphosphate, and phytic acid. See alsoCTFA Dictionary 1734-1735.
- What is meant by “preservatives” is one or more compounds that prevent or reduce or slow down microbial growth and the preservatives are used in an amount which produces the desired function provided that the amount does not effect the stability of the solution. Examples include, but are not limited to, benzoic acid, butylparaben, ethylparaben, propylparaben, methylparaben, sorbic acid, phenoxyethanol, and triclosan. SeeCTFA Dictionary 1765-1766.
- pH Adjusters are also present in some embodiments of the invention and the pH Adjusters are used in an amount which produces the desired function provided that the amount does not effect the stability of the solution. “pH adjuster” are acids or bases that can be used to adjust the pH of the finished product to the desired level. Examples include, but are not limited to, acetic acid, ammonia, citric acid, ethanolamine, formic acid, oxalic acid, potassium hydroxide, sodium hydroxide, and triethanolamine. See also Wenniger and McEwen, eds., 2International Cosmetic Ingredient Dictionary and Handbook 1764 (2000 ed.) (hereinafter “CFTA Dictionary”). All cited references in this application are herein incorporated by reference.
- Further an embodiment of the invention may include one or more moisturizers, preferably propylene glycol and the moisturizers are used in an amount which produces the desired function provided that the amount does not effect the stability of the solution. Additionally, emulsifying agents may be desirable, preferably Ceteareth-20, manufactured by Promateen Chemicals Inc., which is a polyethylene glycol ether of cetearyl alcohol. Ceteareth-20 has 20 moles of ethylene oxide which is added to the non-ionic surfactant to increase its water solubility. In the event that an emulsion stabilizer is used, the preferred one is a mixture of cetyl and stearyl alcohols, sold by Croda Inc. under the name Cetearyl alcohol.
- In order to prevent the degradation caused by oxidation, antioxidants may be included in the formulation and the antioxidants are used in an amount which produces the desired function provided that the amount does not effect the stability of the solution. Antioxidants include, but are not limited to free radical scavengers and reducing agents such as, acetyl cysteine, ascorbic acid, butylated hydroxytoluene, green tea extract, caffeic acid, cysteine, tocopherol, ubiquinone, and propyl gallate, preferably butylated hydroxytoluene (“BHT”). SeeCFTA Dictionary 1727.
- What is meant by “hair conditioning agents” or “conditioning agents” are compounds that can alter the texture, appearance, styling, or feel of the hair and the conditioning agents are used in an amount which produces the desired function provided that the amount does not effect the stability of the solution. Examples include, but are not limited to, alanine, arginine, biotin, calcium panthothenate, dimethicone, cyclomethicone, hydrolyzed plant protein, and polyquaterniums, preferably stearalkonium chloride, sold under the name Ammonyx-4 by Stepan Company. SeeCFTA Dictionary 1752-1759.
- In other embodiments, in addition to the pediculicides, ovacides and Solvent Matrices, these compositions can further comprise adjuvants and the adjuvants are used in an amount which produces the desired function provided that the amount does not effect the stability oft he solution. Examples of adjuvants include, but are not limited to vehicles, stabilizers, moisturizers, cleansing surfactants, emulsifying surfactants, emulsifying stabilizers, foam-boosting surfactants, emollient skin conditioning agents, humectants, hair conditioning agents, buffering agents, pH adjusters, chelating agents, antioxidants, preservatives, botanical extracts, fragrances, and dyes.
- In another embodiment, the composition includes one or more pediculicide and ovacide, the Solvent Matrices, and one or more stabilizers to prevent physical separation of the formulation (“Stabilizers”). Non-acrylic decadiene crosspolymers, including but not limited to Stabileze QM and Stabileze 06 (preferably Stabileze QM) manufactured by International Specialty Products may be employed to stabilize and optionally to thicken the formulations. Stabileze QM and Stabileze 06 are benzene-free copolymers of methyl vinyl ether/maleic anhydride crosslinked with 1,9-decadiene. The INCI name for Stabileze 06 and Stabileze QM is PVM/MA Decadiene crosspolymers. Stabileze 06 has a particle size of <850μ. Stabileze QM has a particle size of <75μ. Since Stabileze QM has a smaller particle size, it may be dispersed faster than Stabileze 06 and may be more rapidly converted to a gel. In some embodiments, a neutralizer of the stabilizer may be required to neutralize the formulation to an approximate pH of 5.5 in order to allow thickening of the formulation. A preferred neutralizer is sodium hydroxide.
- Stabilizers may also include but are not limited to acrylates/aminoacrylates C10-30 Alkyl PEG-20 Itaconate copolymer, long chain acyl derivatives (including but not limited to ethylene glycol distearate and ethylene glycol monostearate), alkanoamides (including but not limited to cocamide MEA), esters of long chain fatty acids (including but not limited to stearyl stearate), alkyl dimethylamine oxides, methylcellulose, hydroxybutyl methylcellulose, hydroxypropylcellulose, hydroxypropyl methylcellulose, hydroxyethyl cellulose, distearyl phthalic amide (e.g. Stephan SAB-2), di(hydrogenated) tallow phthalic amide (e.g. Stephan TAB-2), primary amines with a fatty alkyl moiety of at least 16 carbons (including but not limited to palmitate amine or stearamine), polyacrylic acids, polysaccharide gums (including but not limited to Xanthan Gum), colloidal clays (including but not limited to benzyl dimethyl hydrogenated tallow ammonium montmorillonite) and colloidal silica.
- One of the preferred embodiments is in the form of a conditioner or cream rinse for human hair or animal hair. Hair conditioning agents may be included in the formulation.
- The compositions can be administered topically to an animal, by the direct laying on or spreading of the composition on the skin or hair, preferably of a mammal, most preferably of a human. The compositions useful in the subject invention involve formulations suitable for topical application to mammalian skin or hair. Additionally, the compositions may be made into a wide variety of product types. These include, but are not limited to solutions, aerosols, lotions, creams, gels, sticks, ointments, pastes, cream rinses, shampoos, and body washes. The preferred embodiments are cream rinses, conditioners and shampoos.
- Vehicles include but are not limited to water, propylene glycol, butylene glycol, ethanol, isopropanol, silicones. Preferably, the vehicle is water.
- The invention will be clarified further by a consideration of the following examples.
- Testing of Spinosyn A and Spinosyn D onpediculis captitis Eggs
- Both Spinosyn A and Spinosyn D are sold together as the active ingredient for Conserve SC. Conserve SC is a commercial product from DowElanco used for insect control of turf and ornamental plants. The combination of Spinosyn A and Spinosyn D is known as Spinosad. Conserve SC contains 11.60%, by weight, of the Spinosad. Spinosad contains approximately 80% Spinosyn A and 20% Spinosyn D. Three dilutions of the Conserve SC were created:
- Dilution 1 contained 8.62% Conserve SC, 15% isopropanol, 10% propylene carbonate, and 53.45% deionized water. Dilution 1 resulted in a 1% Spinosad concentration.
- Dilution 2 contained 21.55% Conserve SC, 15% isopropanol, 10% propylene carbonate, and 66.38% deionized water. Dilution 2 resulted in a 2.5% Spinosad concentration.
- Dilution 3 contained 43.10% Conserve SC, 15% isopropanol, 10% propylene carbonate, and 31.9% deionized water. Dilution 3 resulted in a 5% Spinosad concentration.
- An in vitro test of Dilutions 1, 2, and 3 was conducted using fresh specimens ofpediculus capitis eggs. Specimens were collected from volunteers who had abundant nits. Collected eggs were examined for viability. A viable egg is shiny, plump, with an intact operculum, and in more developed eggs, an eye spot. Eggs that were dry, shrunken, indented or otherwise damaged were rejected, as were any eggs containing air pockets.
- The ovacidal assay was conducted at ambient room temperature (25° to 35° C.) and humidity (70-90% RH). Ten hairs with viable eggs were sandwiched between small adhesive labels, allowing 2 cm of the hairs to protrude, with the eggs aligned at the distal end. Immediately prior to testing, the dilutions were shaken thoroughly and dispensed into clean glass vials. The eggs were completely immersed in the formulations for ten minutes. Following immersion, the hair and eggs were rinsed in a gentle stream of filtered water from a squeeze bottle to simulate natural shower conditions. They were allowed to air dry for 30 minutes before being placed in capped vials for incubation at 28° to 32° C., RH 70-90%.
- Ten batches of ten eggs were tested for each dilution for a total of one hundred eggs for each dilution. One hundred untreated eggs and one hundred eggs immersed in water were used as controls.
- Another set of ten batches of ten eggs each (for a total o f 100 eggs) w ere tested o n three successive days. After immersion and rinsing, these eggs were allowed to air dry, and then stored in separate, glass vials. The same eggs were tested on three consecutive days and then left to incubate for two weeks.
- Ovacidal activity was recorded as number of eggs tested, number of eggs hatched, number of eggs not hatched, and number of eggs stillborn. What was meant by “stillborn” referred to the nymphs that reach maturity, are able to lift the operculum, or cap of the egg, but are unable to fully emerge. These stillborn eggs were considered non-viable.
- All three dilutions demonstrated good ovacidal activity. No significant difference in the activity of the dilutions were observed. There was no significant difference between a single treatment of 10 minutes followed by rinsing and a 10-minute treatment on three consecutive days (=3 treatments). The high hatch rates (96% to 98%) of the eggs treated with water in the identical manner as the dilutions indicate that every aspect of the conduct of the test was optimal, including the selection of eggs by the collecting teams, protection of the eggs from heat, lack of contamination by toxic agents on the hands of the collectors and the investigators, and the incubation conditions. Table I shows the ovacidal activity for the single 10-minute immersion followed by a water rinse and two week incubation. Table 2 shows the ovacidal activity for 10-minute immersion on three successive days followed by two week incubation.
TABLE 1 # of Eggs # of Eggs # of Eggs # of Eggs % of Eggs Dilution Tested Hatched Not Hatched Stillborn Hatched Dilution 1 100 1 96 3 1% (1% Spinosad) Dilution 2 100 0 96 4 0% (2.5% Spinosad) Dilution 3 100 2 92 6 2% (5% Spinosad) Water 100 96 4 0 96% Untreated 110 105 5 0 95% -
TABLE 2 # of Eggs # of Eggs # of Eggs # of Eggs % of Eggs Dilution Tested Hatched Not Hatched Stillborn Hatched Dilution 1 100 0 100 0 0% (1% Spinosad) Dilution 2 100 0 98 2 0% (2.5% Spinosad) Dilution 3 100 0 99 1 0% (5% Spinosad) Water 100 98 2 0 98% - In-vitro Ovacidal Testing
- In vitro tests were conducted on human head lice with six formulations in order to study the pediculicidal and ovacidal activity of the formulations. No human subjects were used. The ovacidal results were as follows:
TABLE 3 Active Single Exposure Double Exposure Description Ingredient % Ovacidal Rate Ovacidal Rate Cream Rinse A 1% Spinosad 80% 100% Cream Rinse A1 2% Spinosad 95% 100% Cream Rinse B 1% Spinosad 85% 84% Cream Rinse C 1% Spinosad 76% 94% Nix ® (control) 1% Permethrin 76% 58% Deionized Water 11% 8% - Note that the 76% ovacidal rate for Nix® after single exposure is an outlier versus the prior testing which was usually 50-60% ovacidal rate after single exposure.
TABLE 4 Cream Cream Cream Cream Trade Name INCI Name Rinse A Rinse A1 Rinse B Rinse C Deionized Water 44.8 44.25 44.82 44.81 Stabileze QM PVM/MA 1.1 1.1 1.1 1.1 Decadiene Crosspolymer Propylene Propylene 3 3 3 3 Glycol Glycol Cetostearyl Cetearyl alcohol 3 3 3 3 Alcohol NF Procol-CS-20 Ceteareth-20 0.9 0.9 0.9 0.9 Ammonyx 4 Stearalkonium 4.17 4.17 4.17 4.17 18% Chloride Benzyl Alcohol Benzyl Alcohol 10 10 10 10 Hexylene Hexylene Glycol 6 6 — — Glycol Butylene Glycol Butylene Glycol — — 5 — Dipropylene Dipropylene — — — 5 Glycol Glycol Hydrolite-5 Pentylene 4 4 5 5 Glycol Isopropyl Isopropyl 20 20 20 20 alcohol alcohol Spinosad Spinosyn A & D 1.095 2.19 1.095 1.095 (91.4%) BHT Butylated 0.1 0.1 0.1 0.1 Hydroxytoluene Sodium Sodium 1.83 1.29 1.81 1.82 Hydroxide (10% Hydroxide soln.) 100 100 100 100 - In this test, Single Exposure means that the ova were exposed to the formulation for 10 minutes on Day 1, Double Exposure means that the ova were exposed to the formulation for 10 minutes on Day 1 and Day 4. Ovacidal Rate means the percent of louse ova unhatched after a 14 day incubation period.
- Therefore, all of the cream rinses effectively deliver Spinosad into the louse ova resulting in strong ovacidal activity. Double exposures of Cream Rinse A and Cream Rinse A1 are most effective with 100% mortality rates of the ova in-vitro, while double exposures of any level of Spinosad increases ovacidal effectiveness. Finally, Spinosad 1% and 2 % formulations are superior to Nix®. Nix® is the prior art lice treatment currently marketed to treat lice infestation.
- In-Vitro Pediculicidal Testing
- The following are results taken for the same formulations as Example 3 as tested on adult lice for the pediculicidal rates.
TABLE 5 Single Exposure Single Exposure 1-Minute Immersion 10-Minute Immersion Active % % Ingredient % % Alive & % % Alive & Formulation % Dead Moribund Well Dead Moribund Well A2 0.5% 77% 23% — 100% — — Spinosad A 1% 92% 8% — 100% — — Spinosad A1 2% 82% 18% 100% — — Spinosad B 1% 92% 8% — 97% 3% — Spinosad C 1% 87% 13% — 100% — — Spinosad Nix ® 1% 92% 8% — 92% 8% — Permethrin Deionized — 3% — 97% 2% — 98% Water - All measurements on this chart were taken at 4 hours after exposure. Moribund means that the lice were in terminal stages of life, from which they can never recover any useful function. In this phase, the lice may show signs of central nervous system or peripheral nerve toxicity, such as tremors, convulsions or twitching of a leg or antenna.
- From this study, one can conclude that 0.5%, 1% and 2% Spinosad deliver excellent pediculicidal activity at 1-minute and 10-minute exposure times. Formulations A, A1 and A2 have superior pediculicidal activity to Nixt after a 10-minute immersion time.
TABLE 6 Cream Rinse Trade Name INCI Name A2 Placebo Deionized Water 45.022 46.046 Stabileze QM PVM/MA Decadiene 1.1 1.1 Crosspolymer Propylene Glycol Propylene Glycol 3 3 Cetostearyl Alcohol NF Cetearyl alcohol 3 3 Procol-CS-20 Ceteareth-20 0.9 0.9 Ammonyx 4 (18%) Stearalkonium Chloride 4.17 4.17 Benzyl Alcohol Benzyl Alcohol 10 10 Hexylene Glycol Hexylene Glycol 6 6 Butylene Glycol Butylene Glycol — — Dipropylene Glycol Dipropylene Glycol — — Hydrolite-5 Pentylene Glycol 4 4 Isopropyl alcohol Isopropyl alcohol 20 20 Spinosad (91.4%) Spinosyn A & D 0.548 — BHT Butylated Hydroxytoluene 0.1 0.1 Sodium Hydroxide (10% Sodium Hydroxide 2.16 1.684 soln.) - Since it is critical that the compositions of this invention are not irritants to human skin, we performed a Draize sensitization study (repeat insult patch test) using a placebo (described in the table above) for one of the vehicles. 100 human subjects were involved for 5 weeks. No subject showed sensitization when the vehicle was applied to the skin.
- It is understood that while the invention has been described in conjunction with the detailed description thereof, that the foregoing description is intended to illustrate and not limit the scope of the invention, which is defined by the scope of the appended claims. Other aspects, advantages, and modifications are evident from a review of the following claims.
Claims (74)
2. The composition of claim 1 further comprising one or more stabilizers.
3. The composition of claim 1 , wherein the agents consist of one or more of the following: spinosad, spinosyn A, spinosyn D, any component produced by the Saccharopolyspora spinosa species and a combination thereof.
4. The composition of claim 1 wherein R comprises H.
5. The composition of claim 1 wherein R comprises CH3.
6. The composition of claim 1 wherein R comprises a mixture of H and CH3.
7. The composition of claim 1 wherein R comprises a mixture of H: CH3 wherein the relative structures are in a weight ratio of approximately 85:15.
8. The composition of claim 1 wherein the agents comprise greater than about 0 to about 10 percent of the composition.
9. The composition of claim 1 wherein the agents comprise between about 0.5 to about 5 percent of the composition.
10. The composition of claim 2 , wherein the stabilizers comprise one or more of the group consisting of PVM/MA Decadiene crosspolymers, acrylates/aminoacrylates C10-30 Alkyl PEG-20 Itaconate copolymer, long chain acyl derivatives, alkanolamides, esters of long chain of fatty acids, alkyl dimethylamine oxides, methylcellulose, hydroxybutyl methylcellulose, hydroxypropylcellulose, hydroxypropyl methylcellulose, hydroxethyl cellulose, distearyl phthalic amide, di(hydrogenated) tallow phthalic amide, primary amines with a fatty alkyl moiety of at least 16 carbons, polyacrylic acids, polysaccharide gums, colloidal clays and colloidal silica.
11. The composition of claim 2 , wherein the stabilizers comprise PVM/MA Decadiene crosspolymers.
12. The composition of claim 2 wherein the stabilizers comprise about 0.5 to about 1.5 percent of the composition.
13. The composition of claim 2 wherein the stabilizers have a particle size of less than 75μ.
14. The composition of claim 1 , wherein the solution further comprises a solvent consisting of one or more of the following: benzyl alcohol, pentylene glycol, isopropyl alcohol, hexylene glycol, butylene glycol, and dipropylene glycol.
15. The composition of claim 1 further comprising:
one or more stabilizers;
one or more moisturizers;
one or more emulsion stabilizers;
one or more emulsifying agents;
one or more conditioning agents;
one or more antioxidants; and
one or more pH adjuster.
16. The composition of claim 15 wherein the moisturizer comprises propylene glycol.
17. The composition of claim 15 wherein the emulsion stabilizer comprises a mixture of cetyl and stearyl alcohols.
18. The composition of claim 15 wherein the emulsifying agent comprises Ceteareth-20.
19. The composition of claim 15 wherein the conditioning agent comprises stearalkonium chloride.
20. The composition of claim 15 wherein the antioxidant comprises BHT.
21. The composition of claim 15 wherein the pH adjuster comprises sodium hydroxide.
22. The composition of claim 15 further comprising one or more viscosity increasing agents.
23. The composition of claim 22 wherein the viscosity increasing agent comprises a mixture of cetyl and stearyl alcohols.
25. A composition comprising:
About 44% water;
About 1.1% PVM/MA Decadiene crosspolymers;
About 3% propylene glycol;
About 3% cetearyl alcohol;
About 0.9% ceteareth-20;
About 4.17% stearalkonium chloride;
About 10% benzyl alcohol;
About 6% hexylene glycol;
About 4% pentylene glycol;
About 20% isopropyl alcohol;
About 2.19% mixture of spinosyn A & D in an approximate 85:15 weight ratio;
About 0.1 % BHT; and
About 1.29% sodium hydroxide (10% solution).
26. A composition comprising:
Water;
A PVM/MA Decadiene crosspolymers;
Propylene glycol;
A mixture of cetyl and stearyl alcohols;
Ceteareth-20;
Stearalkonium chloride;
Benzyl alcohol;
Pentylene glycol;
Isopropyl alcohol;
A mixture of spinosyn A and spinosyn D in a weight ratio of approximately 85:15;
BHT; and
Sodium hydroxide.
27. A method of controlling adults and ova of the species of order Anoplura by topically applying to one or more of skin and hair a composition comprising:
an effective amount of one or more agents having pediculicidal and ovacidal properties in solution;
wherein the agents comprise a chemical structure of:
28. The method of claim 27 wherein the composition further comprises one or more stabilizers.
29. The method of claim 27 , wherein the agents consist of one or more of the following: spinosad, spinosyn, spinosyn A, spinosyn D, any component produced by the Saccharopolyspora spinosa species and a combination thereof.
30. The method of claim 27 , wherein R comprises H.
31. The method of claim 27 , wherein R comprises CH3.
32. The method of claim 27 , wherein R comprises a mixture of H:CH3.
33. The method of claim 27 , wherein R comprises a mixture of H:CH3 wherein the relative structures are in a weight ratio of approximately 85:15.
34. The method of claim 27 , wherein the agents comprise greater than about 0 to about 10 percent of the composition.
35. The method of claim 27 wherein the agents comprise between about 0.5 to about 5 percent of the composition.
36. The method of claim 28 , wherein the stabilizers comprise one or more of the group consisting of PVM/MA Decadiene crosspolymers, acrylates/aminoacrylates C10-30 Alkyl PEG-20 Itaconate copolymer, long chain acyl derivatives, alkanolamides, esters of long chain of fatty acids, alkyl dimethylamine oxides, methylcellulose, hydroxybutyl methylcellulose, hydroxypropylcellulose, hydroxypropyl methylcellulose, hydroxyethyl cellulose, distearyl phthalic amide, di(hydrogenated) tallow phthalic amide, primary amines with a fatty alkyl moiety of at least 16 carbons, polyacrylic acids, polysaccharide gums, colloidal clays and colloidal silica.
37. The method of claim 28 , wherein the stabilizer comprise PVM/MA decadiene crosspolymers.
38. The method of claim 28 wherein the stabilizers comprises about 0.5 to about 1.5 percent of the composition.
39. The method of claim 28 wherein the stabilizers have a particle size of <75μ.
40. The method of claim 27 , wherein the solution further comprises a solvent consisting of one or more of the following: benzyl alcohol, pentylene glycol, isopropyl alcohol, hexylene glycol, butylene glycol, and dipropylene glycol.
41. The method of claim 27 further comprising:
one or more stabilizers;
one or more moisturizers;
one or more emulsion stabilizers;
one or more emulsifying agents;
one or more conditioning agents;
one or more antioxidants; and
one or more pH adjuster.
42. The method of claim 41 wherein the moisturizer comprises propylene glycol.
43. The method of claim 41 wherein the emulsion stabilizer comprises a mixture of cetyl and stearyl alcohols.
44. The method of claim 41 wherein the emulsifying agent comprises Ceteareth-20.
45. The method of claim 41 wherein the conditioning agent comprises stearalkonium chloride.
46. The method of claim 41 wherein the antioxidant comprises BHT.
47. The method of claim 41 wherein the pH adjuster comprises sodium hydroxide.
48. The method of claim 41 further comprising one or more viscosity increasing agents.
49. The method of claim 48 wherein the viscosity increasing agent comprises a mixture of cetyl and stearyl alcohols.
50. A method of controlling adults and ova of the species of order Anoplura by topically applying to one or more of skin and hair a composition comprising:
an effective amount of one or more agents having pediculicidal and ovacidal properties in solution;
wherein the agents comprise a chemical structure of:
and
one or more stabilizers.
51. A method of controlling adults and ova of the species of order Anoplura by topically applying to one or more of skin and hair a composition comprising:
about 44% water;
about 1.1 % PVM/MA decadiene crosspolymer;
About 3% propylene glycol;
About 3% cetearyl alcohol;
About 0.9% ceteareth-20;
About 4.17% stearalkonium chloride;
About 10% benzyl alcohol;
About 6% hexylene glycol;
About 4% pentylene glycol;
About 20% isopropyl alcohol;
About 2.19% mixture of spinosyn A and spinosyn D in an approximate 85:15 weight ratio;
About 0.1 % BHT; and
1.29% sodium hydroxide (10% solution).
53. The method of claim 52 further comprising adding one or more stabilizers.
54. The method of claim 52 , wherein the agents consist of one or more of the following: spinosad, spinosyn, spinosyn A, spinosyn D, any component produced by the Saccharopolyspora spinosa species and a combination thereof.
55. The method of claim 52 , wherein R comprises H.
56. The method of claim 52 , wherein R comprises CH3.
57. The method of claim 52 , wherein R comprises a mixture of H:CH3.
58. The method of claim 52 , wherein R comprises a mixture of H:CH3 wherein the relative structures are in a weight ratio of approximately 85:15.
59. The method of claim 52 , wherein the agents comprise greater than about 0 to about 10 percent of the composition.
60. The method of claim 52 wherein the agents comprise between about 0.5 to about 5 percent of the composition.
61. The method of claim 53 , wherein the stabilizers comprise one or more of the group consisting of PVM/MA Decadiene crosspolymers, acrylates/aminoacrylates C10-30 Alkyl PEG-20 Itaconate copolymer, long chain acyl derivatives, alkanolamides, esters of long chain of fatty acids, alkyl dimethylamine oxides, methylcellulose, hydroxybutyl methylcellulose, hydroxypropylcellulose, hydroxypropyl methylcellulose, hydroxyethyl cellulose, distearyl phthalic amide, di(hydrogenated) tallow phthalic amide, primary amines with a fatty alkyl moiety of at least 16 carbons, polyacrylic acids, polysaccharide gums, colloidal clays and colloidal silica.
62. The method of claim 53 , wherein the stabilizer comprise PVM/MA decadiene crosspolymers.
63. The method of claim 53 wherein the stabilizers comprises about 0.5 to about 1.5 percent of the composition.
64. The method of claim 53 wherein the stabilizers have a particle size of <75μ.
65. The method of claim 52 further comprising adding a solvent consisting of one or more of the following: benzyl alcohol, pentylene glycol, isopropyl alcohol, hexylene glycol, butylene glycol, and dipropylene glycol.
66. The method of claim 52 further comprising adding one or more stabilizers; one or more moisturizers; one or more emulsion stabilizers; one or more emulsifying agents; one or more conditioning agents; one or more antioxidants; and one or more pH adjuster.
67. The method of claim 66 wherein the moisturizer comprises propylene glycol.
68. The method of claim 66 wherein the emulsion stabilizer comprises a mixture of cetyl and stearyl alcohols.
69. The method of claim 66 wherein the emulsifying agent comprises Ceteareth-20.
70. The method of claim 66 wherein the conditioning agent comprises stearalkonium chloride.
71. The method of claim 66 wherein the antioxidant comprises BHT.
72. The method of claim 66 wherein the pH adjuster comprises sodium hydroxide.
73. The method of claim 66 further comprising adding one or more viscosity increasing agents.
74. The method of claim 73 wherein the viscosity increasing agent comprises a mixture of cetyl and stearyl alcohols.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/638,452 US20040048813A1 (en) | 2001-04-25 | 2003-08-11 | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/841,715 US6727228B2 (en) | 2001-04-25 | 2001-04-25 | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
US10/230,460 US7030095B2 (en) | 2001-04-25 | 2002-08-29 | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
US10/638,452 US20040048813A1 (en) | 2001-04-25 | 2003-08-11 | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/230,460 Division US7030095B2 (en) | 2001-04-25 | 2002-08-29 | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040048813A1 true US20040048813A1 (en) | 2004-03-11 |
Family
ID=25285532
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/841,715 Expired - Fee Related US6727228B2 (en) | 2001-04-25 | 2001-04-25 | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
US10/230,460 Expired - Fee Related US7030095B2 (en) | 2001-04-25 | 2002-08-29 | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
US10/638,452 Abandoned US20040048813A1 (en) | 2001-04-25 | 2003-08-11 | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
US10/726,241 Abandoned US20040109883A1 (en) | 2001-04-25 | 2003-12-02 | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
US11/238,316 Abandoned US20060024345A1 (en) | 2001-04-25 | 2005-09-29 | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/841,715 Expired - Fee Related US6727228B2 (en) | 2001-04-25 | 2001-04-25 | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
US10/230,460 Expired - Fee Related US7030095B2 (en) | 2001-04-25 | 2002-08-29 | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/726,241 Abandoned US20040109883A1 (en) | 2001-04-25 | 2003-12-02 | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
US11/238,316 Abandoned US20060024345A1 (en) | 2001-04-25 | 2005-09-29 | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
Country Status (12)
Country | Link |
---|---|
US (5) | US6727228B2 (en) |
EP (1) | EP1252820B1 (en) |
JP (1) | JP2003012522A (en) |
KR (1) | KR20020083144A (en) |
CN (1) | CN1382375A (en) |
AT (1) | ATE320713T1 (en) |
AU (1) | AU3439702A (en) |
BR (1) | BR0201412A (en) |
CA (1) | CA2382806A1 (en) |
DE (1) | DE60210012T2 (en) |
ES (1) | ES2260391T3 (en) |
MX (1) | MXPA02004088A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030051061A1 (en) * | 2001-09-04 | 2003-03-13 | Peter Hank | Acceptance filter |
US20080320084A1 (en) * | 2007-06-22 | 2008-12-25 | Alcatel Lucent | System for providing information to users sharing a nomadic experience |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0118137D0 (en) | 2001-07-25 | 2001-09-19 | Syngenta Ltd | Insecticidal mixture |
US7812163B2 (en) | 2003-07-16 | 2010-10-12 | Hatchtech Pty Ltd. | Methods and compositions for controlling ectoparasites |
AU2003903686A0 (en) | 2003-07-16 | 2003-07-31 | Hatchtech Pty Ltd | Methods and compositions for controlling ectoparasites |
AU2004319804B2 (en) | 2004-04-29 | 2010-08-05 | Elanco Us Inc. | Use Of Spinosyns For Wound Healing |
SG159395A1 (en) * | 2004-04-29 | 2010-03-30 | Lilly Co Eli | Use of spinosyns for wound healing |
US20070027119A1 (en) * | 2005-07-29 | 2007-02-01 | Ahmed Fahim U | Antibacterial composition and method of use |
US8778369B2 (en) * | 2005-07-29 | 2014-07-15 | Delaval Holding Ab | Barrier film-forming compositions and methods of use |
US7964205B2 (en) * | 2005-09-16 | 2011-06-21 | W. Neudorff Gmbh Kg | Insecticide and molluscicide composition and methods |
US8007820B2 (en) * | 2005-09-16 | 2011-08-30 | W. Neudorff Gmbh Kg | Wide spectrum insecticide and miticide composition |
TW200740369A (en) * | 2005-11-01 | 2007-11-01 | Dow Agrosciences Llc | Pesticidally active compositions having enhanced activity |
AU2006315084B2 (en) * | 2005-11-18 | 2013-01-24 | Symbion Pty Ltd | Pediculicide/ovicide composition |
US20080019939A1 (en) * | 2006-07-20 | 2008-01-24 | Alberto-Culver Company | Conditioner formulation |
US8791153B2 (en) * | 2006-10-12 | 2014-07-29 | Sanofi-Topaz, Inc. | Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice |
KR100855417B1 (en) * | 2006-10-27 | 2008-08-29 | 일라이 릴리 앤드 캄파니 | A Pharmaceutical Composition for Wound Healing Comprising Spinosyns |
EP2141991A4 (en) * | 2007-04-05 | 2011-06-15 | Hatchtech Pty Ltd | Compositions and methods for controlling infestation |
US20090061630A1 (en) * | 2007-08-30 | 2009-03-05 | Dupont Air Products Nanomaterials Llc | Method for Chemical Mechanical Planarization of A Metal-containing Substrate |
EP2033518A1 (en) * | 2007-09-06 | 2009-03-11 | Cheminova A/S | Pesticidal compositions |
AU2009296674B2 (en) * | 2008-09-23 | 2015-01-29 | Larada Sciences Inc. | Airflow applicators and related treatment methods |
TWI510189B (en) | 2009-06-19 | 2015-12-01 | Lilly Co Eli | Ectoparasiticidal methods and formulations |
US9253979B2 (en) * | 2010-12-29 | 2016-02-09 | Dow Agrosciences Llc | Methods of controlling insects |
WO2013019824A2 (en) * | 2011-08-02 | 2013-02-07 | Dow Agrosciences Llc | Pesticidal compositions and processes related thereto |
CN102676393B (en) * | 2011-12-16 | 2014-02-26 | 天津北洋百川生物技术有限公司 | Saccharopolyspora spinosa for producing spinosad and culture and application of saccharopolyspora spinosa |
US9895388B1 (en) * | 2012-07-27 | 2018-02-20 | ParaPRO | Methods and compositions useful for controlling cutaneous mites |
CN104822263B (en) | 2012-11-14 | 2017-06-13 | 伊莱利利公司 | Kill ectoparasite method and formulation |
WO2015107384A2 (en) | 2013-12-17 | 2015-07-23 | Hatchtech Pty Ltd. | Pediculicidal composition |
KR101716795B1 (en) * | 2014-07-31 | 2017-03-16 | 우석대학교 산학협력단 | Novel Saccharopolyspora spinosa wsp8209 Producing Spinosad with High Yield and Method for Producing Spinosad |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5202242A (en) * | 1991-11-08 | 1993-04-13 | Dowelanco | A83543 compounds and processes for production thereof |
US5362634A (en) * | 1989-10-30 | 1994-11-08 | Dowelanco | Process for producing A83543 compounds |
US5496931A (en) * | 1988-12-19 | 1996-03-05 | Dowelanco | Insecticide and miticide A83543 compounds and their method of production by fermentation |
US5539089A (en) * | 1991-11-08 | 1996-07-23 | Dowelanco | A83543 aglycones and pseudoglycones |
US5591606A (en) * | 1992-11-06 | 1997-01-07 | Dowelanco | Process for the production of A83543 compounds with Saccharopolyspora spinosa |
US5670364A (en) * | 1993-03-12 | 1997-09-23 | Dowelanco | A83543 compounds and process for production thereof |
US5712295A (en) * | 1994-06-07 | 1998-01-27 | Bayer Aktiengesellschaft | Agonists and antagonists of the nicotinic acetylcholine receptors of insects to control endoparasites |
US5817608A (en) * | 1996-08-26 | 1998-10-06 | Brimms Inc. | Cleansing compositions containing conditioning agents and refined agricultural grains |
US5972987A (en) * | 1999-03-16 | 1999-10-26 | Lori Fox Reid | Method for removing nits from hair |
US6063771A (en) * | 1998-07-02 | 2000-05-16 | Eli Lilly And Company | Formulations for controlling human lice |
US6106815A (en) * | 1995-12-26 | 2000-08-22 | Cheil Jedang Corporation | Shampoo composition containing methyl vinyl ether/maleic anhydride decadiene crosspolymer and capsules |
US6113888A (en) * | 1999-06-15 | 2000-09-05 | Neutrogena Corporation | Self-tanning mousse |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE196599T1 (en) | 1993-01-19 | 2000-10-15 | Nicholas V Dr Perricone | AGENTS FOR TOPICAL APPLICATION TO THE SKIN FOR THE TREATMENT AND/OR PREVENTION OF SKIN DAMAGE CAUSED BY RADIATION |
US5653970A (en) * | 1994-12-08 | 1997-08-05 | Lever Brothers Company, Division Of Conopco, Inc. | Personal product compositions comprising heteroatom containing alkyl aldonamide compounds |
WO2000060940A1 (en) | 1999-04-12 | 2000-10-19 | Dow Agrosciences Llc | Aqueous dispersions of agricultural chemicals |
US6933318B1 (en) * | 1999-08-12 | 2005-08-23 | Eli Lilly And Company | Topical organic ectoparasiticidal formulations |
EP1207757B1 (en) | 1999-08-12 | 2005-02-23 | Eli Lilly And Company | Ectoparasiticidal aqueous suspension formulations of spinosyns |
HUP0202823A2 (en) | 1999-08-12 | 2003-03-28 | Lilly Co Eli | Topical organic ectoparasiticidal formulations |
-
2001
- 2001-04-25 US US09/841,715 patent/US6727228B2/en not_active Expired - Fee Related
-
2002
- 2002-04-18 AU AU34397/02A patent/AU3439702A/en not_active Abandoned
- 2002-04-22 CA CA002382806A patent/CA2382806A1/en not_active Abandoned
- 2002-04-24 DE DE60210012T patent/DE60210012T2/en not_active Expired - Fee Related
- 2002-04-24 AT AT02252881T patent/ATE320713T1/en not_active IP Right Cessation
- 2002-04-24 BR BR0201412-2A patent/BR0201412A/en not_active IP Right Cessation
- 2002-04-24 MX MXPA02004088A patent/MXPA02004088A/en active IP Right Grant
- 2002-04-24 ES ES02252881T patent/ES2260391T3/en not_active Expired - Lifetime
- 2002-04-24 JP JP2002122779A patent/JP2003012522A/en active Pending
- 2002-04-24 EP EP02252881A patent/EP1252820B1/en not_active Expired - Lifetime
- 2002-04-24 CN CN02118656A patent/CN1382375A/en active Pending
- 2002-04-25 KR KR1020020022756A patent/KR20020083144A/en not_active Application Discontinuation
- 2002-08-29 US US10/230,460 patent/US7030095B2/en not_active Expired - Fee Related
-
2003
- 2003-08-11 US US10/638,452 patent/US20040048813A1/en not_active Abandoned
- 2003-12-02 US US10/726,241 patent/US20040109883A1/en not_active Abandoned
-
2005
- 2005-09-29 US US11/238,316 patent/US20060024345A1/en not_active Abandoned
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5496931A (en) * | 1988-12-19 | 1996-03-05 | Dowelanco | Insecticide and miticide A83543 compounds and their method of production by fermentation |
US5571901A (en) * | 1988-12-19 | 1996-11-05 | Dowelanco | Insecticide and miticide compositions containing A83543 compounds |
US5362634A (en) * | 1989-10-30 | 1994-11-08 | Dowelanco | Process for producing A83543 compounds |
US5539089A (en) * | 1991-11-08 | 1996-07-23 | Dowelanco | A83543 aglycones and pseudoglycones |
US5202242A (en) * | 1991-11-08 | 1993-04-13 | Dowelanco | A83543 compounds and processes for production thereof |
US5767253A (en) * | 1992-11-06 | 1998-06-16 | Dow Agrosciences Llc | A83543 Compounds; factors Q, R, S, and T |
US5591606A (en) * | 1992-11-06 | 1997-01-07 | Dowelanco | Process for the production of A83543 compounds with Saccharopolyspora spinosa |
US5631155A (en) * | 1992-11-06 | 1997-05-20 | Dowelanco | Saccharopolyspora spinosa strain |
US5670364A (en) * | 1993-03-12 | 1997-09-23 | Dowelanco | A83543 compounds and process for production thereof |
US5712295A (en) * | 1994-06-07 | 1998-01-27 | Bayer Aktiengesellschaft | Agonists and antagonists of the nicotinic acetylcholine receptors of insects to control endoparasites |
US6106815A (en) * | 1995-12-26 | 2000-08-22 | Cheil Jedang Corporation | Shampoo composition containing methyl vinyl ether/maleic anhydride decadiene crosspolymer and capsules |
US5817608A (en) * | 1996-08-26 | 1998-10-06 | Brimms Inc. | Cleansing compositions containing conditioning agents and refined agricultural grains |
US6063771A (en) * | 1998-07-02 | 2000-05-16 | Eli Lilly And Company | Formulations for controlling human lice |
US6342482B1 (en) * | 1998-07-02 | 2002-01-29 | Eli Lilly And Company | Formulations for controlling human lice |
US5972987A (en) * | 1999-03-16 | 1999-10-26 | Lori Fox Reid | Method for removing nits from hair |
US6113888A (en) * | 1999-06-15 | 2000-09-05 | Neutrogena Corporation | Self-tanning mousse |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030051061A1 (en) * | 2001-09-04 | 2003-03-13 | Peter Hank | Acceptance filter |
US20080320084A1 (en) * | 2007-06-22 | 2008-12-25 | Alcatel Lucent | System for providing information to users sharing a nomadic experience |
Also Published As
Publication number | Publication date |
---|---|
EP1252820B1 (en) | 2006-03-22 |
US7030095B2 (en) | 2006-04-18 |
KR20020083144A (en) | 2002-11-01 |
US20030087838A1 (en) | 2003-05-08 |
EP1252820A1 (en) | 2002-10-30 |
US20030026822A1 (en) | 2003-02-06 |
CN1382375A (en) | 2002-12-04 |
US20040109883A1 (en) | 2004-06-10 |
ES2260391T3 (en) | 2006-11-01 |
ATE320713T1 (en) | 2006-04-15 |
US20060024345A1 (en) | 2006-02-02 |
JP2003012522A (en) | 2003-01-15 |
DE60210012D1 (en) | 2006-05-11 |
DE60210012T2 (en) | 2007-03-29 |
US6727228B2 (en) | 2004-04-27 |
BR0201412A (en) | 2003-06-10 |
AU3439702A (en) | 2002-10-31 |
MXPA02004088A (en) | 2004-05-05 |
CA2382806A1 (en) | 2002-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7030095B2 (en) | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs | |
US11229207B2 (en) | Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice | |
US7064108B2 (en) | Topical ivermectin composition | |
US9955695B2 (en) | Pediculicide/ovicide composition | |
US20080275107A1 (en) | Topical formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice with multiple modes of action | |
AU2006233158A1 (en) | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs | |
JP2006508957A (en) | Combined products for controlling pests | |
JPH0624911A (en) | Use of undecylenic acid or undecanic acid derivative for killing louse | |
US7294342B2 (en) | Ectoparasite asphyxiator compositions and methods for their application | |
US20060140995A1 (en) | Methods for treating ectoparasite infections on the mammalian body | |
US20040013700A1 (en) | Compositions for treating ectoparasite infections and methods for their application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: JOHNSON & JOHNSON COMPANIES, INC., NEW JERSEY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:JANSSEN, HERWIG;HO, KIE;NYSTRAND, GLENN;AND OTHERS;REEL/FRAME:014393/0068;SIGNING DATES FROM 20010412 TO 20010420 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |